G

ood morning, everyone, and welcome to another working week. We hope the weekend respite — which was longer than usual on the side of the pond — was refreshing and invigorating, because that oh-so-familiar routine of meetings and deadlines and the like has predictably returned. There is only one thing to do in the face of such business — fire up the coffee kettle and brew several cups of stimulation. We are enjoying cinnamon vanilla for those who are curious about such things. Meanwhile, here are a few items of interest. Hope your day is smashing and please do keep in touch …

A confidential Department of Justice report shows federal prosecutors investigating Purdue Pharma found the company knew about “significant” OxyContin abuse in the first years after introducing the drug in 1996 and concealed the information, The New York Times reports. Purdue officials received reports the pills were being crushed and snorted; stolen from pharmacies; and some doctors were being charged with selling prescriptions. But Purdue continued to market OxyContin as less prone to abuse and addiction than other prescription opioids, prosecutors wrote in 2006.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy